↓ Skip to main content

Role of Survivin in Bladder Cancer: Issues to Be Overcome When Designing an Efficient Dual Nano-Therapy

Overview of attention for article published in Pharmaceutics, November 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
12 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Role of Survivin in Bladder Cancer: Issues to Be Overcome When Designing an Efficient Dual Nano-Therapy
Published in
Pharmaceutics, November 2021
DOI 10.3390/pharmaceutics13111959
Pubmed ID
Authors

Maria Arista-Romero, Anna Cascante, Cristina Fornaguera, Salvador Borrós

Twitter Demographics

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 17%
Unspecified 1 8%
Other 1 8%
Student > Bachelor 1 8%
Lecturer 1 8%
Other 2 17%
Unknown 4 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 17%
Unspecified 1 8%
Chemical Engineering 1 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 8%
Physics and Astronomy 1 8%
Other 0 0%
Unknown 6 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 December 2021.
All research outputs
#13,227,671
of 23,310,485 outputs
Outputs from Pharmaceutics
#1,234
of 5,422 outputs
Outputs of similar age
#197,636
of 510,022 outputs
Outputs of similar age from Pharmaceutics
#105
of 478 outputs
Altmetric has tracked 23,310,485 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,422 research outputs from this source. They receive a mean Attention Score of 3.9. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 510,022 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 478 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.